Piper Jaffray Downgrades MedAssets To Underweight, PT To $15

February 25, 2011 7:04 AM | 8 seconds read | Make a Comment

Piper Jaffray has downgraded MedAssets, Inc.

MDAS

from Neutral to Underweight and has lowered the price target from $21 to $15.

Posted In: Downgrades Price Target Analyst Ratings Health Care Health Care Technology medassets Piper Jaffray

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.